GE Healthcare Technologies Inc (GEHC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ryan Zimmerman from BTIG reiterated a Buy rating on the stock and has a $82.00 price target.
Ryan Zimmerman has given his Buy rating due to a combination of factors including GE Healthcare Technologies Inc’s resilience in a challenging macroeconomic environment. Despite a significant drop in share price due to global trade tensions and concerns over imaging demand, the company demonstrated strong order growth and exceeded revenue and earnings expectations.
GEHC has effectively mitigated over half of its tariff exposure through strategic internal actions and a substantial share buyback program. Zimmerman believes that as the macroeconomic conditions improve, the company’s shares will recover, justifying the Buy rating. The adjusted price target reflects a lower assumed multiple and earnings forecast, but it still acknowledges the company’s improved execution and potential for recovery.
In another report released on April 24, DBS also maintained a Buy rating on the stock with a $80.00 price target.